1. Protein Tyrosine Kinase/RTK
  2. FGFR
  3. HuGAL-FR21

HuGAL-FR21 是一种人源化的抗 FGFR2IIIb IgG1 单克隆抗体。HuGAL-FR21 可以阻断 FGF2FGF7FGF10 与 FGFR2IIIb 的结合并抑制 FGF 诱导的 FGFR2IIIb 磷酸化。HuGAL-FR21 可以下调 SNU-16 细胞中 FGFR2 的表达。HuGAL-FR21 在裸鼠胃癌异种移植物模型中表现出显著的抗肿瘤活性。HuGAL-FR21 可用于癌症如胃癌的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

HuGAL-FR21

HuGAL-FR21 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
1 mg   询价  
5 mg   询价  
10 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

HuGAL-FR21 is a humanized antiFGFR2IIIb IgG1 monoclonal antibody. HuGAL-FR21 can block the binding of FGF2, FGF7, and FGF10 to FGFR2IIIb and inhibit FGF-induced phosphorylation of FGFR2IIIb. HuGAL-FR21 can downregulate the expression of FGFR2 in SNU-16 cells. HuGAL-FR21 shows the significant anti-tumor activity in athymic nude mice bearing gastric cancer xenograft models. HuGAL-FR21 can be used for research on cancer such as gastric cancer[1].

反应种属

Human

IC50 & Target[1]

FGFR2

 

体外研究
(In Vitro)

HuGAL-FR21 (0.001-1 μg/mL) 在 SNU-16 细胞中可以特异性结合 FGFR2IIIb (EC50 约 20 pM) 及其突变体 S252W[1]
HuGAL-FR21 (0.01-100 μg/mL) 有效阻断 FGFR2IIIb (IC50 约 1.5-3 μg/mL) 与 FGF2、FGF7 和 FGF10 的结合[1]
HuGAL-FR21 (10 μg/mL,30 分钟) 有效阻断 SNU-16 细胞中 FGF7 诱导的磷酸化,显著抑制 SNU-16 细胞中 FGF2 诱导的磷酸化[1]
HuGAL-FR21 (10 μg/mL,2-24 小时) 下调 SNU-16 细胞中 FGFR2 蛋白水平[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: SNU-16 cells
Concentration: 10 μg/mL
Incubation Time: 2, 8 and 48 h
Result: Reduced the level of FGFR2 protein by approximately 50%.
体内研究
(In Vivo)

HuGAL-FR21 (0.5-5 mg/kg,腹腔注射,每周两次,持续 25-30 天) 在裸鼠 SNU-16/OCUM-2M 异种移植模型中可有效抑制肿瘤生长且无明显毒性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 5×106 SNU-16 or OCUM-2M cells injected female athymic nude mice (5-6 weeks)[1]
Dosage: 0.5, 1, 2.5 and 5 mg/kg in SNU-16 model, 1 and 2.5 mg/kg in OCUM-2M model
Administration: Intraperitoneal injection (i.p.); twice weekly for 25 days in SNU-16 model and 30 days in OCUM-2M model
Result: Significantly inhibited the growth of SNU-16 and OCUM-2M tumors.
Did not show any other obvious toxicity.
基因 ID

2263  [NCBI]

Accession
靶点

FGFR2/CD332

应用

ELISA, FACS, Functional assay

偶联物

Unconjugated

复溶方法

The product can be reconstituted/diluted with sterile PBS or saline.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
HuGAL-FR21
目录号:
HY-P991584
需求量: